Home/Filings/4/0000899243-18-014563
4//SEC Filing

Wechsler Daniel Mark 4

Accession 0000899243-18-014563

CIK 0001461993other

Filed

May 30, 8:00 PM ET

Accepted

May 31, 5:13 PM ET

Size

5.0 KB

Accession

0000899243-18-014563

Insider Transaction Report

Form 4
Period: 2018-05-29
Wechsler Daniel Mark
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2018-05-29$5.00/sh+50,000$250,00050,000 total
Footnotes (1)
  • [F1]These shares were purchased from the underwriters pursuant to an underwritten public offering by the Issuer. The offering closed on May 29, 2018.

Issuer

MELINTA THERAPEUTICS, INC. /NEW/

CIK 0001461993

Entity typeother

Related Parties

1
  • filerCIK 0001582285

Filing Metadata

Form type
4
Filed
May 30, 8:00 PM ET
Accepted
May 31, 5:13 PM ET
Size
5.0 KB